Quality of life benefits of idelalisib with rituximab for patients with previously treated chronic lymphocytic leukaemia

Authors:

Sullivan W, Lee D, Perard R, Ysebaert L and Leblond V.

Publication Type:

Conference Proceedings – Poster

Publication Name:

20th Congress of the European Hematology Association (EHA)

Citation:

Sullivan W, Lee D, Perard R, Ysebaert L and Leblond V. Quality of life benefits of idelalisib with rituximab for patients with previously treated chronic lymphocytic leukaemia. 20th Congress of the European Hematology Association (EHA). Vienna, Austria. 11-16 June 2015. Poster P214.


Link to publication ⟶

⟵ Back to Search Results

By continuing to browse or by clicking "Accept All Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookie Policy
Accept All Cookies
By continuing to browse or by clicking "Accept All Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookie Policy
Accept All Cookies